Novartis' cardiovascular trial shows no significant effect

Statements (2)

1. ● Neutral

   Novartis' cardiovascular candidate data showed no significant effect in its pivotal trial.

   endpoints.newsNov 7, 2026 14:50 UTC
2. ● Neutral

   Novartis failed to lower the risk of heart attack or stroke despite lowering a risk marker for cardiovascular disease at the AHA conference

   statnews.comNov 7, 2026 14:50 UTCHigh importance